An issue of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) bonds fell 0.8% against their face value during trading on Monday. The high-yield issue of debt has a 5.125% coupon and will mature on July 1, 2022. The debt is now trading at $102.00 and was trading at $103.00 one week ago. Price moves in a company’s bonds in credit markets often predict parallel moves in its share price.

A number of analysts have commented on the stock. BMO Capital Markets cut their price objective on shares of Acadia Healthcare from $52.00 to $48.00 and set an “outperform” rating for the company in a report on Thursday, October 26th. Robert W. Baird downgraded shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and cut their price objective for the company from $55.00 to $38.00 in a report on Wednesday, October 25th. Jefferies Group LLC set a $42.00 price objective on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Wednesday, October 25th. Bank of America Corporation cut their price objective on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a report on Wednesday, October 25th. Finally, Mizuho downgraded shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and set a $36.00 price objective for the company. in a report on Sunday. Two research analysts have rated the stock with a sell rating, five have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $47.46.

Shares of Acadia Healthcare Company, Inc. (ACHC) traded down 3.89% during mid-day trading on Wednesday, hitting $30.14. 784,027 shares of the stock were exchanged. The company has a 50-day moving average of $43.53 and a 200 day moving average of $45.93. The stock has a market cap of $2.65 billion, a PE ratio of 331.21 and a beta of 1.07. Acadia Healthcare Company, Inc. has a one year low of $30.11 and a one year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The company had revenue of $716.70 million for the quarter, compared to analyst estimates of $728.86 million. During the same period last year, the company posted $0.58 EPS. The business’s revenue for the quarter was down 2.4% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post $2.26 earnings per share for the current year.

In related news, EVP Christopher L. Howard sold 16,762 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total transaction of $879,502.14. Following the completion of the transaction, the executive vice president now owns 200,999 shares of the company’s stock, valued at $10,546,417.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the transaction, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. Insiders have sold 1,842,802 shares of company stock valued at $93,443,510 in the last ninety days. 11.10% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of ACHC. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after purchasing an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. acquired a new stake in shares of Acadia Healthcare in the second quarter worth $205,000. Riverhead Capital Management LLC acquired a new stake in shares of Acadia Healthcare in the second quarter worth $209,000. Paloma Partners Management Co acquired a new stake in shares of Acadia Healthcare in the first quarter worth $217,000. Finally, Rathbone Brothers plc acquired a new stake in shares of Acadia Healthcare in the third quarter worth $223,000.

ILLEGAL ACTIVITY WARNING: “Acadia Healthcare Company, Inc. (ACHC) Bond Prices Fall 0.8%” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://theolympiareport.com/2017/11/01/acadia-healthcare-company-inc-achc-bond-prices-fall-0-8.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.